We are monitoring the impact of COVID-19 on Asia Pacific Non-Invasive Cancer Diagnostics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 5366
Share on
Share on

Asia Pacific Non-Invasive Cancer Diagnostics Market Research Report - Segmented By Therapeutics, Techniques & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 5366
Pages: 145

Asia Pacific Non-Invasive Cancer Diagnostics Market Size & Growth (2019 – 2024):

The Size of the Non-Invasive Cancer Diagnostics Market in the Asia Pacific is valued at USD xx million in 2019 and estimated to grow at a CAGR of xx.xx%, to reach USD xx million by 2024 during the forecast period 2019-2024.

A medical procedure is referred to as non- invasive when there is a slight incision in the body in diagnosis. There are various non- invasive diagnostics methods which range from simple observation to specialized surgery.

The significant drivers are increasing the incidence of cancer due to aging, and increasing awareness about the early cancer diagnosis. Advancements in cancer detection techniques are also expected to drive the market over the forecast period. However, the high cost of treatment is a major restraint limiting this industry.

Asia Pacific Non-Invasive Cancer Diagnostics Market has been segmented and sub-segmented into the following categories

  • By Therapeutics: Blood cancer, Breast Cancer, Lung Cancer, Solid tumors
  • By Techniques: Immunochemistry, Clinical Chemistry, Molecular Diagnostics.
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC.

On the basis of region, the Asia Pacific has significant growth owing to the growing population and growing government initiatives.

Top Companies leading the Asia Pacific Non-Invasive Cancer Diagnostics Market Profiled in the Report are Precision Therapeutics, Laboratory Corporation of America Holdings (LabCorp), BIOVIEW Inc.,   Affymetrix Inc., AVIVA Biosciences Corporation, A&G Pharmaceutical, Quest Diagnostics Incorporated Cancer Genetics Inc., Digene Corporation and Gen-Probe Incorporated.

1. Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Techniques                 

       5.1.1 Introduction           

       5.1.2 Clinical Chemistry 

       5.1.3 Immunochemistry/Immunoassay 

       5.1.4 Molecular Diagnostics        

       5.1.5 Other Clinical Instruments

       5.1.6  Y-o-Y Growth Analysis, By Techniques       

       5.1.7  Market Attractiveness Analysis, By Techniques     

       5.1.8  Market Share Analysis, By Techniques       

                5.2 Type     

       5.2.1 Introduction           

       5.2.2 Breast Cancer        

       5.2.3 Blood cancer          

       5.2.4 Lung Cancer            

       5.2.5 Solid tumors           

       5.2.6 Others      

       5.2.5 Y-o-Y Growth Analysis, By Type     

       5.2.6 Market Attractiveness Analysis, By Type   

       5.2.7 Market Share Analysis, By Type     

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Techniques

                       6.1.3.3 By Type

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Techniques

                       6.1.4.3 By Type

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Techniques

                       6.1.5.3 By Type

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia        

                6.7 Rest of APAC              

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 AVIVA Biosciences Corporation

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Affymetrix Inc. 

                8.3 A&G Pharmaceutical     

                8.4 BIOVIEW Inc.    

                8.5 Digene Corporation                

                8.6 Gen-Probe Incorporated                      

                8.7 Laboratory Corporation of America Holdings (LabCorp) 

                8.8 Precision Therapeutics 

                8.9 Quest Diagnostics Incorporated                        

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  •  Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type and  with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2019-2024 ( USD Million )
  2. Asia Pacific Clinical Chemistry Market By Region, From 2019-2024 ( USD Million )
  3. Asia Pacific Immunochemistry/Immunoassay Market By Region, From 2019-2024 ( USD Million )
  4. Asia Pacific Molecular Diagnostics Market By Region, From 2019-2024 ( USD Million )
  5. Asia Pacific Other Clinical Instruments Market By Region, From 2019-2024 ( USD Million )
  6. Asia Pacific Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2019-2024 ( USD Million )
  7. Asia Pacific Breast Cancer Market By Region, From 2019-2024 ( USD Million )
  8. Asia Pacific Blood cancer Market By Region, From 2019-2024 ( USD Million )
  9. Asia Pacific Lung Cancer Market By Region, From 2019-2024 ( USD Million )
  10. Asia Pacific Solid tumors Market By Region, From 2019-2024 ( USD Million )
  11. Asia Pacific Others Market By Region, From 2019-2024 ( USD Million )
  12. Japan Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2019-2024 ( USD Million )
  13. Japan Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2019-2024 ( USD Million )
  14. China Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2019-2024 ( USD Million )
  15. China Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2019-2024 ( USD Million )
  16. India Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2019-2024 ( USD Million )
  17. India Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2019-2024 ( USD Million )
  18. Australia Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2019-2024 ( USD Million )
  19. Australia Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2019-2024 ( USD Million )
  20. South Korea Non-Invasive Cancer Diagnostics Market By  TECHNIQUES, From 2019-2024 ( USD Million )
  21. South Korea Non-Invasive Cancer Diagnostics Market By THERAPEUTICS, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample